Sanofi CEO Finally Scores With $11.6B Buyout of Biogen's Spinoff Bioverativ Post author:Sam Post published:January 21, 2018 Post category:BioPharma The deal has Sanofi paying $105 per share in cash. Source: BioSpace You Might Also Like BrainStorm Cell Names And To Its Board Of Directors As Company Prepares For Clinical And Commercial Success February 26, 2017 Biotech Pioneer Submits Regulation A+ Filing With For Up To $50 Million Initial Public Offering September 6, 2017 ASLAN To Present At Biopharma Asia Convention 2017 March 16, 2017
BrainStorm Cell Names And To Its Board Of Directors As Company Prepares For Clinical And Commercial Success February 26, 2017
Biotech Pioneer Submits Regulation A+ Filing With For Up To $50 Million Initial Public Offering September 6, 2017
